Kirn David
SEC insider (Form 3/4/5 filer). CIK 0001834021. Director at 4D Molecular Therapeutics, Inc. (FDMT). 15 reported Form 4/5 transactions since Sep 2024; latest on Oct 5, 2026. Located in EMERYVILLE, CA.
Companies Kirn David has filed insider reports for
- 4D Molecular Therapeutics, Inc. (FDMT): Director, Officer, See Remarks
Kirn David
CIK: 0001834021
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
4D Molecular Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Oct 5, 2026FDMT
4D Molecular Therapeutics, Inc.
SaleDirect58.1K shares at avg. $12.92$750K - Oct 5, 2026FDMT
4D Molecular Therapeutics, Inc.
SaleDirect272 shares at avg. $13.61$4K - Sep 14, 2026FDMT
4D Molecular Therapeutics, Inc.
SaleDirect58.3K shares at avg. $13.90$811K - Aug 19, 2026FDMT
4D Molecular Therapeutics, Inc.
SaleDirect25.9K shares at avg. $16.42$426K - Aug 19, 2026FDMT
4D Molecular Therapeutics, Inc.
SaleDirect43.1K shares at avg. $15.36$663K - Aug 19, 2026FDMT
4D Molecular Therapeutics, Inc.
ExerciseDirect50K shares at avg. $4.14$207K - Aug 4, 2026FDMT
4D Molecular Therapeutics, Inc.
SaleDirect26.8K shares at avg. $10.23$275K - Aug 3, 2026FDMT
4D Molecular Therapeutics, Inc.
SaleDirect12.4K shares at avg. $10.05$125K - Jul 10, 2026FDMT
4D Molecular Therapeutics, Inc.
SaleDirect442 shares at avg. $12.84$6K - Jul 10, 2026FDMT
4D Molecular Therapeutics, Inc.
SaleDirect15.3K shares at avg. $12.01$184K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 5, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Sale | 58,061 | $12.92 | $750,235 | Direct |
| Oct 5, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Sale | 272 | $13.61 | $3,702 | Direct |
| Sep 14, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Sale | 58,333 | $13.90 | $811,004 | Direct |
| Aug 19, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Sale | 25,927 | $16.42 | $425,651 | Direct |
| Aug 19, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Sale | 43,149 | $15.36 | $662,622 | Direct |
| Aug 19, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Exercise | 50,000 | $4.14 | $207,000 | Direct |
| Aug 4, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Sale | 26,842 | $10.23 | $274,596 | Direct |
| Aug 3, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Sale | 12,415 | $10.05 | $124,722 | Direct |
| Jul 10, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Sale | 442 | $12.84 | $5,673 | Direct |
| Jul 10, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Sale | 15,283 | $12.01 | $183,560 | Direct |
1-10 of 15 transactions